Geode Capital Management, LLC Imago Bio Sciences, Inc. Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$15.03 - $35.96 $309,753 - $741,099	20,609 Added 4.61%	467,992 $16.8 Million
Q3 2022 Nov 14, 2022	BUY	$14.15 - $19.5 $1.99 Million - $2.75 Million	140,887 Added 45.97%	447,383 $6.73 Million
Q2 2022 Aug 12, 2022	BUY	$11.81 - $20.92 $501,428 - $888,221	42,458 Added 16.08%	306,496 $4.1 Million
Q1 2022 May 13, 2022	BUY	$16.97 - $25.0 $1.69 Million - $2.49 Million	99,425 Added 60.4%	264,038 $5.09 Million
Q4 2021 Feb 11, 2022	BUY	$16.22 - $29.69 $321,139 - $587,832	19,799 Added 13.67%	164,613 $3.9 Million
Q3 2021 Nov 12, 2021	BUY	$16.0 - $28.84 $2.32 Million - $4.18 Million	144,814 New	144,814 $2.9 Million

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.